Physician

Thomas Sanders Hughes, MD

According to 2025 Medicare claims, Thomas Hughes, MD (NPI: 1831379213) practices neurology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is TIDEWATER NEUROLOGY (NPI: 1962454124; TIN: 202191546) and primary practice location at 29464-3667.

Hughes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,000 traditional Medicare patients, billed 201,317 HCPCS/CPT codes, and received $1,418,485 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 4,303 prescription claims across 739 beneficiaries totaling $952,154 in drug costs, led by Nuplazid (Pimavanserin Tartrate). DME data shows 714 claims. Open Payments data shows 261 records totaling $5,079. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $384,457 to $1,418,485. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $933,282 and ending at $952,154. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $24,548 and ending at $39,658.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	813	22,238	$384,457
2016	823	25,269	$415,535
2017	813	30,610	$485,875
2018	832	24,303	$434,907
2019	790	15,862	$290,242
2020	714	17,336	$278,911
2021	684	22,226	$453,749
2022	678	30,691	$631,305
2023	688	44,166	$1,186,520
2024	1,000	201,317	$1,418,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	495	3,310	$933,282
2016	518	3,570	$940,507
2017	544	3,692	$1,577,176
2018	557	3,680	$1,587,587
2019	575	3,875	$1,357,331
2020	540	3,762	$2,607,773
2021	506	3,386	$1,151,758
2022	490	3,264	$1,043,379
2023	495	3,152	$904,112
2024	739	4,303	$952,154

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	82	209	$6,746
2016	74	241	$6,603
2017	135	374	$9,667
2018	186	396	$11,533
2019	230	506	$15,907
2020	233	615	$18,548
2021	210	535	$17,043
2022	193	445	$14,738
2023	181	404	$13,072
2024	348	714	$24,632

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	107	107	$286
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	257	257	$157
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	156	196	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	775	1,546	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	359	467	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nuplazid	Pimavanserin Tartrate	21	630	$104,186
Zeposia	Ozanimod Hydrochloride	11	330	$97,788
Kesimpta Pen	Ofatumumab	11	308	$96,091
Ubrelvy	Ubrogepant	40	1,134	$60,762
Nuedexta	Dextromethorphan Hbr/Quinidine	23	810	$46,647

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	25	132	$4,039
A7030	Full face mask used with positive airway pressure device, each	N	23	39	$3,044
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	37	55	$2,882
A7031	Face mask interface, replacement for full face mask, each	N	19	40	$2,753
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	42	65	$2,420

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	261	$5,079	EMD Serono, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Thomas Sanders Hughes, MD?

Tedicare shows public-source Medicare data for Thomas Sanders Hughes, MD (NPI 1831379213), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas Sanders Hughes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas Sanders Hughes, MD?

Thomas Sanders Hughes, MD is linked to TIDEWATER NEUROLOGY (billing NPI 1962454124) in the available physician profile data.

Does Thomas Sanders Hughes, MD have Open Payments data?

Thomas Sanders Hughes, MD has 261 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.